跳至主要内容
临床试验/JPRN-UMIN000042533
JPRN-UMIN000042533已完成未知

Glycemic and insulinemic response after oral ingestion of HBF2020-04 - Glycemic and insulinemic response after oral ingestion of HBF2020-04

Oneness Support Co., Ltd.0 个研究点目标入组 20 人开始时间: 2020年11月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • [1] Who have a disease and/or surgical history of serious hepatopathy, kidney damage, gastrointestinal disease, heart disease, peripheral vascular disorder, others which may affect the results of the study. [2] Who with liver disorder, and/or kidney disorder. [5] who are under medical treatments. [6] Who are allergic to foods and/or medicines. [7] Who are diagnosed as anemia. [8] Who play intense sports and/or on a diet. [10] Who use supplements which may affect the results of the study. [11] Who take medicines. [12] Who daily take excessive alcohol, and/or can't abstinent from alcohol from the day before the each examinations. [13] Who are or are possibly pregnant, or who are lactating, during the study period. [14] Who are participating or are willing to participate in other studies. [15] Who are judged inappropriate for the study by the investigator

研究者

发起方
Oneness Support Co., Ltd.

相似试验